# A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

> **NCT02242396** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 5248 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Telmisartan hydrochlorothiazide

## Key facts

- **NCT ID:** NCT02242396
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 5248 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242396, "A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02242396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*